Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

• Status: Recruiting
• Trial end date: 2021-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

We will compare between Carbitocin and Misoprostol in prevention of postpartum hemorrhage in high risk patients after C.S.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beni-Suef University
• Collaborator: Cairo University
• Treatments: Carbetocin; Misoprostol; Oxytocin

Criteria

Inclusion Criteria:

• Women with a singleton pregnancy undergoing cesarean section after 37 weeks of gestation.

Any medical disorder with pregnancy that carries a risk factor for PPH.

Exclusion Criteria:

• Women undergoing cesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only.

• women undergoing cesarean section at less than 37 weeks of gestation.